News

May 11, 2016May 11, 2016

Sunovion to Present New Data on Brovana Inhalation Solution for COPD

Chronic Bronchitis, COPD, Emphysema, News

Sunovion Pharmaceuticals, Inc. will present new data analyses regarding its Brovana® (arformoterol tartrate) Inhalation Solution, from clinical and health outcomes in chronic obstructive pulmonary disease (COPD) patients, at the 2016 American ... Read more

May 10, 2016May 11, 2016

Galectin Therapeutics Preclinical Research on Galectin-3 Role in PAH to be Presented at ATS 2016

News, Pulmonary Hypertension

Galectin Therapeutics, Inc., a biopharmaceutical company that develops therapeutic compounds that bind and inhibit galectin proteins with pathological activity, announced recently that its collaborative abstract on galectin-3 and its role ... Read more

May 9, 2016May 9, 2016

Asthma and Lung Damage Study Led by Hospital for Sick Children Receives Funding from Canadian Institutes of Health Research

Asthma, COPD, News

A study led by Hospital for Sick Children (SickKids) researchers investigating the influence of genes and environment on lung health will receive $1.9 million in funding over the next five years. ... Read more

May 9, 2016May 9, 2016

Insmed Incorporated to Present Data on Liposomal Technology To Treat PAH, IPF at 2016 American Thoracic Society Meeting

Asthma, News, Pulmonary Hypertension

Insmed Incorporated recently announced that it will present three ARIKAYCE™-related abstracts and one treprostinil prodrug abstract at the American Thoracic Society (ATS) 2016 International Conference in San Francisco, May 13-18. ARIKAYCE™ ... Read more

May 9, 2016May 9, 2016

May is US Asthma Awareness Month

Asthma, News

Asthma patients know that springtime brings additional challenges and symptoms. Establishing May as the U.S. Asthma Awareness Month is an initiative to raise awareness of symptom triggers and health risk factors ... Read more

May 6, 2016May 6, 2016

Concert Pharmaceuticals Announces Promising Phase 1 Trial Data on Modified Version of CF Treatment Ivacaftor

Cystic Fibrosis, News

Promising clinical data from a Phase 1 multiple ascending trial of a deuterium-modified version of the commercially available Kalydeco® (ivacaftor), a drug used to treat cystic fibrosis (CF) in patients ... Read more

May 6, 2016May 6, 2016

CF Foundation Appoints Marc Ginsky as Executive Vice President and Chief Operating Officer

Cystic Fibrosis, News

The Cystic Fibrosis Foundation (CFF), a leading supporter of research into new treatments for cystic fibrosis (CF), recently announced the appointment of Marc Ginsky as its executive vice president and chief ... Read more

May 5, 2016May 5, 2016

AVEO Oncology Files Provisional Patent Applications for AV-353 for PAH Treatment

News, Pulmonary Hypertension

AVEO Oncology recently filed provisional patent applications with the United States Patent and Trademark Office (USPTO) covering composition of matter claims for AV-353, its Notch 3 inhibitory antibody. These are the ... Read more

May 5, 2016May 5, 2016

Rapid Diagnostic Test for Mycoplasma pneumoniae Receives EU Mark of Approval

News, Pneumonia

Meridian Bioscience, Inc., recently announced that its new molecular diagnostic test for Mycoplasma pneumoniae, illumigene Mycoplasma Direct assay, has received the CE mark, which establishes that the product meet the European Union’s safety, health ... Read more

May 5, 2016May 13, 2016

Cempra Asks FDA to Approve Antibiotic to Treat Community-Acquired Bacterial Pneumonia

News, Pneumonia

Cempra, Inc., announced that it has completed its rolling submission of a New Drug Application for solithromycin, a potential treatment for community-acquired bacterial pneumonia (CABP), to the U.S. Food and Drug Administration. The ... Read more